NO20024289L - Preparat for behandling av hjertesvikt - Google Patents

Preparat for behandling av hjertesvikt

Info

Publication number
NO20024289L
NO20024289L NO20024289A NO20024289A NO20024289L NO 20024289 L NO20024289 L NO 20024289L NO 20024289 A NO20024289 A NO 20024289A NO 20024289 A NO20024289 A NO 20024289A NO 20024289 L NO20024289 L NO 20024289L
Authority
NO
Norway
Prior art keywords
treatment
disorders
preparation
viral
heart disorders
Prior art date
Application number
NO20024289A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024289D0 (no
Inventor
Elizabeth Louise Jones
Original Assignee
Medinnova Sf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0005867.7A external-priority patent/GB0005867D0/en
Priority claimed from GB0027661A external-priority patent/GB0027661D0/en
Application filed by Medinnova Sf filed Critical Medinnova Sf
Publication of NO20024289D0 publication Critical patent/NO20024289D0/no
Publication of NO20024289L publication Critical patent/NO20024289L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20024289A 2000-03-10 2002-09-09 Preparat for behandling av hjertesvikt NO20024289L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0005867.7A GB0005867D0 (en) 2000-03-10 2000-03-10 Method
GB0027661A GB0027661D0 (en) 2000-11-13 2000-11-13 Method
PCT/GB2001/001054 WO2001066124A2 (en) 2000-03-10 2001-03-09 Composition for the treatment of heart failure

Publications (2)

Publication Number Publication Date
NO20024289D0 NO20024289D0 (no) 2002-09-09
NO20024289L true NO20024289L (no) 2002-11-11

Family

ID=26243851

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024289A NO20024289L (no) 2000-03-10 2002-09-09 Preparat for behandling av hjertesvikt

Country Status (8)

Country Link
EP (1) EP1267905B1 (de)
JP (1) JP2003525905A (de)
AT (1) ATE305311T1 (de)
AU (1) AU4079001A (de)
CA (1) CA2400504A1 (de)
DE (1) DE60113664T2 (de)
NO (1) NO20024289L (de)
WO (1) WO2001066124A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
AUPS194902A0 (en) * 2002-04-24 2002-06-06 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
EP1755642B1 (de) * 2004-04-15 2010-01-13 Athera Biotechnologies Ab Annexin zur prävention von der ruptur des plaques
US8025634B1 (en) * 2006-09-18 2011-09-27 Baxter International Inc. Method and system for controlled infusion of therapeutic substances
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
AU2008300516A1 (en) * 2007-09-20 2009-03-26 Bracco Imaging Spa Method for the preparation of new oligoclonal antibodies
EP2230251A1 (de) * 2009-03-19 2010-09-22 Bracco Imaging S.p.A Antikörper, die speziell im Koronarplaque aktiv sind und Verfahren zur ihrer Identifizierung
WO2013148708A1 (en) 2012-03-26 2013-10-03 Xcellcure, Llc Device and method for detection of analytes
US10087238B2 (en) 2017-02-22 2018-10-02 Kuwait University Method of preventing myocardial reperfusion injury in reperfusion therapy by administering intravenous immunoglobulin
KR102549282B1 (ko) * 2019-11-18 2023-06-30 건국대학교 산학협력단 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
WO1994028932A1 (en) * 1993-06-11 1994-12-22 Sangstat Medical Corporation Immunoglobulin infusion in xenotransplantation
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
WO2001066124A2 (en) 2001-09-13
AU4079001A (en) 2001-09-17
NO20024289D0 (no) 2002-09-09
DE60113664D1 (de) 2006-02-09
EP1267905A2 (de) 2003-01-02
WO2001066124A3 (en) 2002-03-28
ATE305311T1 (de) 2005-10-15
JP2003525905A (ja) 2003-09-02
CA2400504A1 (en) 2001-09-13
DE60113664T2 (de) 2006-07-06
EP1267905B1 (de) 2005-09-28

Similar Documents

Publication Publication Date Title
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
ATE309999T1 (de) Blutplättchen-adp-rezeptor-inhibitoren
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
EP1734041A3 (de) Platelet adp rezeptor inhibitoren
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
ATE403430T1 (de) Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz
NO20033862L (no) Fremgangsmåte for prevensjon eller terapi av inflammatoriske eller autoimmune lidelser ved administrering av integrin-alfa-beta3-antagonisteri kombinasjonmed andre profylaktiske eller terapeutiske midler
NO20024289D0 (no) Preparat for behandling av hjertesvikt
NO20041070L (no) Preparat for behandling av vanlig forkjolelse.
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
DK1202736T3 (da) Nikotin i terapeutisk angiogenese og vasculogenese
BR0308739A (pt) Tratamentos em combinação para doenças mediadas por quimiocina
WO2004020410A3 (en) Dihydropyridinone derivatives as hne inhibitors
SE9903759D0 (sv) Pharmaceutically active compounds
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
WO2002004421A3 (en) Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
WO2003082196A3 (en) Combination therapy using trefoil peptides
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
SE0101932D0 (sv) Pharmaceutical combinations
EP1195166A3 (de) Verwendung von einem Vasopressin-Antagonist wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
WO2002085358A3 (en) Antiviral agents and methods of treating viral infections
ATE365549T1 (de) Mittel gegen stressinduzierte krankheiten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application